Clinical trial
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced…
NCT00005814 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005814 |
|---|---|
| Title | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer |
| Official title | Phase II Study of C225 in Combination With Cisplatin and Standard/Delayed Accelerated Hyperfractionated Radiation Therapy in Patients With Advanced Head & Neck Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | cetuximab, cisplatin, radiation therapy |
| Start date | Dec 1, 1999 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | May 20, 2004 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: